Case Report: Coexistence of anti-LGI1 and anti-mGluR2 antibodies in an autoimmune encephalitis patient., PMID:40519939
Case Report: Anti-ADAM23 antibody: an overlooked autoantibody against VGKC-complex in autoimmune encephalitis., PMID:40519920
Paraneoplastic Limbic Encephalitis in a Patient With Thymoma., PMID:40519393
Leucine-rich glioma-inactivated 1 (LGI-1) autoimmune encephalitis presenting as reversible cerebral vasoconstriction syndrome: Initial case report from India., PMID:40488299
Clinical Characteristics and Seizure Outcomes in Antibody-Positive Autoimmune Limbic Encephalitis., PMID:40463859
Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1-ADAM22/23 pathway., PMID:40455867
Paraneoplastic LGI1 Encephalitis Associated with Lung Adenocarcinoma: A Case Report., PMID:40407616
[Anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis diagnosed from T1 signal intensity changes in basal ganglia: a case report and literature review]., PMID:40399057
Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (II): Antibodies to Surface Antigens., PMID:40393020
Clinical, Electroencephalogram and Imaging Characteristics of Patients With Anti-LGI1 Antibody Encephalitis: A Multicenter Cohort Study., PMID:40322833
Comparison of commercial and in-house tissue-based and cell-based assays for the detection of autoantibodies targeting neuronal surface proteins: a prospective cohort study., PMID:40303411
Multimodal prognostication of autoimmune encephalitis: an Australian autoimmune encephalitis consortium study., PMID:40281286
Neurodegeneration and the immune system: lessons from autoimmune encephalitis., PMID:40274643
Rituximab for Leucine-Rich Glioma-Inactivated 1 (LGI1) Antibody-Related Super-refractory Status Epilepticus: A Case Report and Literature Review., PMID:40271344
Successful treatment of morvan syndrome with efgartigimod: report of two cases., PMID:40268813
From immunobiology to intervention: Pathophysiology of autoimmune encephalitis., PMID:40267699
Electroencephalographic biomarkers of antibody-mediated autoimmune encephalitis., PMID:40206289
Long-Term Seizure Outcomes in Autoimmune Encephalitis., PMID:40182605
Leucine-rich glioma-inactivated protein 1 antibody-positive limbic encephalitis in a patient with an early-stage asymptomatic breast cancer., PMID:40180343
Neuroglia in autoimmune encephalitis., PMID:40148042
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2., PMID:40131535
Current and emerging therapies for autoimmune encephalitis., PMID:40125911
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review., PMID:40116573
Activated αβ T- and reduced mucosa-associated invariant T cells in LGI1- and CASPR2-encephalitis., PMID:40094812
Prevalence, clinical profiles, and prognosis of Isaacs syndrome: A nationwide survey study in Japan., PMID:40058033
Microglial Activation Visualized by [18F]-DPA714 PET Is a Potential Marker of Severity and Prognosis for Anti-LGI1 Encephalitis., PMID:40052391
Clinical, radiological, pathological and prognostic features of general paresis: a cohort study., PMID:40036706
A Case of Anti-LGI1 Limbic Encephalitis Presenting With Non-convulsive Status Epilepticus and Requiring a Long Period of Hospitalization., PMID:40007925
Capturing what matters: Patient-reported LGI1-ANTibody encephalitis outcome RatiNg scale (LANTERN)., PMID:39996410
Abnormal CSF-Specific OCBs in Neuronal Surface Antibody-Associated Autoimmune Encephalitis Differentiating from Viral Encephalitis., PMID:39991667
GAD antibodies in neurological disease: a critical evaluation of the utility and treatment implications of GAD antibodies in clinical practice., PMID:39985693
Distinctive seizure signature in the first video case-control study of a naturally-occurring feline autoimmune encephalitis model., PMID:39984138
Patient-derived monoclonal LGI1 autoantibodies elicit seizures, behavioral changes and brain MRI abnormalities in rodent models., PMID:39984135
Autoimmune encephalitis associated with anti-LGI1 antibody: a potential cause of neuropsychiatric systemic lupus erythematosus., PMID:39965877
Enigmatic intractable Epilepsy patients have antibodies that bind glutamate receptor peptides, kill neurons, damage the brain, and cause Generalized Tonic Clonic Seizures., PMID:39932550
Autoimmune Encephalitis., PMID:39893022
Hippocampal dysfunction after autoimmune encephalitis depending on the antibody type., PMID:39891731
Update on autoimmune dementia and its precursors., PMID:39889830
Cognitive Deficits in Anti-LGI1 Encephalitis Are Linked to Immunotherapy-Resistant White Matter Network Changes., PMID:39879565
Rare mixed dementia: A case report., PMID:39876884
Acute Hyperhidrosis: A Clue to Underlying Autonomic Dysfunction and a Rare Neurological Disorder., PMID:39867015
Varied Clinical Features and Outcomes of Autoimmune Encephalitis: A Retrospective Case Series., PMID:39866989
Autoimmune encephalitis: recovery, residual symptoms and predictors of long-term sequelae., PMID:39832911
Efgartigimod treatment for therapy-refractory autoimmune encephalitis with coexistent NMDAR and LGI1 antibodies: a case report and literature review., PMID:39820999
Diagnostic utility of magnetic resonance imaging in autoimmune encephalitis: prognostic implications., PMID:39764590
Identifying Key Prognostic Indicators for Relapse and Chronic Epilepsy in Autoimmune Encephalitis: Insights from a Multicenter Retrospective Study., PMID:39735892
LGI1 encephalitis manifesting as a delayed paraneoplastic response of squamous cell lung cancer on remission., PMID:39734683
Recent advances in autoimmune encephalitis., PMID:39706227
Acute Bilateral Vocal Cord Paralysis in a Patient With Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Limbic Encephalitis., PMID:39664290
Anti-LGI1 Autoimmune Limbic Encephalitis: An Easy-To-Miss Diagnosis., PMID:39651393
For research use only. Not for human or drug use.
